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Abstract
The rapid technological development of high-throughput genomics has given rise
to complex high-dimensional microarray datasets. One strategy for reducing the di-
mensionality of microarray experiments is to carry out a cluster analysis to ﬁnd groups
of genes with similar expression patterns. Though cluster analysis has been studied
extensively, the clinical context in which the analysis is performed is usually consid-
ered separately if at all. However, allowing clinical outcomes to inform the clustering
of microarray data has the potential to identify gene clusters that are more useful for
describing the clinical course of disease.
The aim of this dissertation is to utilize outcome information to drive the cluster-
ing of gene expression data. In Chapter 1, we propose a joint clustering model that
assumes a relationship between gene clusters and a continuous patient outcome. Gene
expression is modeled using cluster speciﬁc random effects such that genes in the same
cluster are correlated. A linear combination of these random effects is then used to de-
scribe the continuous clinical outcome. We implement a Markov chain Monte Carlo
algorithm to iteratively sample the unknown parameters and determine the cluster
pattern. Chapter 2 extends this model to binary and failure time outcomes. Our strat-
egy is to augment the data with a latent continuous representation of the outcome and
specify that the risk of the event depends on the latent variable. Once the latent vari-
able is sampled, we relate it to gene expression via cluster speciﬁc random effects and
apply the methods developed in Chapter 1. The setting of clustering longitudinal mi-
croarrays using binary and survival outcomes is considered in Chapter 3. We propose
a model that incorporates a random intercept and slope to describe the gene expression
iiitime trajectory. As before, acontinuous latent variablethat is linearly related to the ran-
dom effects is introduced into the model and a Markov chain Monte Carlo algorithm
is used for sampling. These methods are applied to microarray data from trauma pa-
tients in the Inﬂammation and Host Response to Injury research project. The resulting
partitions are visualized using heat maps that depict the frequency with which genes
cluster together.
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Microarray Data
Jessie J. Hsu, Dianne M. Finkelstein, and David A. Schoenfeld
Department of Biostatistics, Harvard School of Public Health
Biostatistics Center, Massachusetts General Hospital1.1 Introduction
In the past decade, new technologies for high-throughput genomics and proteomics
have developed with the potential of revolutionizing medicine. Gene expression mi-
croarrays are one such technology that measure the levels of RNA expression in a cell.
These expression levels are constantly changing, producing a rich inﬂux of informa-
tion. Due to the wealth of potential knowledge encoded in the human genome that is
captured in microarray experiments, there is substantial interest in identifying differ-
ential gene expression patterns and relating gene activity to phenotypic information.
Our goal is to reduce a microarray dataset into clusters of genes that are biologically
meaningful and to use those clusters to predict patient outcome. We would like to ﬁnd
clusters of genes that are both correlated with each other as well as associated with pa-
tientoutcome, andwehypothesizethatusingoutcomeinformationtodrivethepattern
discovery can potentially result in gene clusters that are more coherent and biologically
meaningful. We are motivated by the Inﬂammation and Host Response to Injury re-
search program, also known as the Glue Grant (http://www.gluegrant.org). The Glue
Grant is a large-scale interdisciplinary study of inﬂammation following severe trauma
or burn injury. The immune system reacts to injury by activating the inﬂammation
response in an attempt to prevent further damage to the body, and presumably the
chain of events that takes place as the body tries to stabilize and recover is reﬂected
in differential gene expression. The general aims of the Glue Grant are to uncover the
biological reasons why patients have such varying responses following their injury, to
understand the genomic and proteomic markers that predict clinical outcomes, and to
determine the relationship between changes in gene expression and clinical features.
For this paper, we focus on the association between patterns in differential gene ex-
pression and metabolic recovery in patients with severe trauma.
Many methods have been developed for relating gene expression to clinical outcomes,
most of which involve reducing the dimensionality of the gene expression data. One
2way to go about this is to identify a subset of genes that are predictive markers of out-
come. The simplest method for subset selection is univariate variable selection, where
each gene is individually tested for signiﬁcance and the top ranked ones are included
in a multivariate model. Stepwise selection procedures achieve the same end but can
be unstable for high-dimensional datasets. Increased stability and reduced prediction
error can be obtained by penalized regression methods which operate by imposing
a constraint on the parameters, leading to coefﬁcient shrinkage (Tibshirani, 1996). In
particular, lasso simultaneously obtains parameter estimates and achieves variable se-
lectionbecausetheabsolutevalueconstraintcausessomecoefﬁcientstobeestimatedat
exactly zero. Dimension reduction can also be accomplished by principal components
regression (Hastie et al., 2001a). This is an unsupervised procedure that reduces the
gene expression values down to their principal components and incorporates the ﬁrst
few components that explain the majority of the predictor variation into a regression
model. A supervised version of this approach is partial least squares regression (PLSR)
(Park et al., 2002). Here, both the predictors and outcome are decomposed such that
the latent vectors used in the decomposition maximize their covariance. Given that our
goal of using outcome information to drive the data reduction is partially addressed
by PLSR, we will use it for comparison to our method.
Clustering is another widely used form of microarray dimension reduction that is
based on the assumption that groups of genes are more similar to each other than oth-
ers for reasons such as related functionality, shared biological pathways, or a similar
effect on outcome. One approach, though computationally burdensome, is to perform
a stochastic search across the entire space of possible partitions and select the true
clustering to be the one with the highest likelihood. Another approach is to cluster
the genes across patient samples via a technique such as K-means and then to use the
cluster expression averages in a regression model (Eisen et al., 1998). K-means cluster-
ing is a classic clustering algorithm that ﬁnds the partition of K sets that minimizes the
distance of each observation to its center, where each cluster center is the mean of the
3observations in that cluster (Hartigan, 1975). Achieving the optimal clustering using
K-means with a Euclidean distance metric is equivalent to maximizing the likelihood
that corresponds to modeling gene expression as a normally distributed cluster spe-
ciﬁc ﬁxed effect. The maximum likelihood occurs when each gene is assigned to its
nearest cluster center such that the within cluster sum of squares is minimized. This
approach operates under the assumption that all the genes to be clustered are inde-
pendent. This is appropriate for clustering independent individuals but is ﬂawed for
clustering features that have a correlation structure. Rather, it is more reasonable to
state that genes in the same cluster are correlated while genes across different clusters
are independent. Furthermore, K-means assumes that there is only one correct cluster-
ing pattern and does not provide a measure of uncertainty associated with the cluster
assignments.
A related formulation of the clustering problem is the normal mixture model, where
each observation is viewed as arising from a mixture of distributions. Fraley and
Raftery (1998) and Ghosh and Chinnaiyan (2002) discussed model-based clustering
where the gene expression data is modeled as a normal mixture and clusters are de-
termined by the Expectation-Maximization (EM) algorithm. A Bayesian approach can
also be used to ﬁt the mixture model (Vogl et al., 2005). In these approaches, the prob-
ability distribution of each gene is modeled as the sum of K weighted underlying dis-
tributions, each representing the distribution of a gene conditional on membership in
each cluster. The entire data likelihood is then a product across all the genes. Once
again, this approach fails to specify any sort of correlation between genes in the same
cluster. These types of mixture models are valid for clustering patients, but do not
reasonably extend to the setting of clustering features measured on each patient.
The statistically sound approach for model-based clustering is to include a random
effect such that highly correlated genes fall in the same cluster. Ng et al. (2006) imple-
mented an EM algorithm to ﬁt the random effects model for clustering. Alternatively,
the Bayesian paradigm provides a uniﬁed framework for ﬁtting complex hierarchical
4models. For example, Booth et al. (2008) proposed a random effects clustering model
and performed a stochastic search for clusters using the posterior distribution of the
unknown partition as the objective function. Tadesse et al. (2005) presented a Markov
chain Monte Carlo (MCMC) sampling scheme for simultaneously selecting discrimi-
nating genes and clustering patients. The advantage of the Bayesian approach is that
it accounts for uncertainty in all of the parameters, including variation about cluster
membership. It can incorporate prior information and naturally allows outcome to
drive the clustering of the genes when ﬁtting the joint model.
The notion of outcome-informed clustering has been studied less extensively. Hastie
et al. (2001b) touched upon the idea of informative clustering in his proposal of a su-
pervised approach called ‘tree-harvesting’ where clusters of genes are explored in a
stepwise fashion and related to outcome using the intermediate results of hierarchical
clustering. Dettling and B¨ uhlmann (2002) discussed a strategy that directly incorpo-
rates the response variable into the clustering process by using a rank-based test statis-
tic for ﬁnding groups of genes that discriminate a categorical response. Ideally, one
would like to simultaneously ﬁnd clusters and model the outcome such that each part
is inﬂuenced by the other.
In this chapter, we propose a joint model for simultaneously clustering correlated gene
expression data and predicting a continuous patient outcome. We use a random effects
model for describing gene expression cluster membership and relate the latent cluster
effects to a continuous patient outcome via a linear model. We develop a MCMC clus-
tering algorithm for model ﬁtting and parameter inference based on a marginalized
likelihood. By simultaneously modeling patient outcome with gene expression and
developing a clustering algorithm that makes use of clinical data, we will generate
clusters that are more useful for describing the clinical course of injury.
Our methodology is described in Section 1.2. The results of simulation studies are pre-
sented in Section 1.3, and an analysis of the Glue Grant data is presented in Section 1.4.
5We conclude with a discussion in Section 1.5.
1.2 Methods
1.2.1 Model Speciﬁcation
We propose a joint model for clustering correlated gene expression data that is driven
by a continuous patient outcome. Consider representing the microarray dataset as a
N J matrix consisting of gene expression values for J genes measured on N patients.
Let Yij be the gene expression value for patient i and gene j belonging in cluster k.
Conditional on membership of gene j in the kth cluster, the random effects model for
describing gene expression is
Yij = cik(j) + ij (1.1)
where i = 1;:::;N;j = 1;:::;J; and k = 1;:::;K. Here, cik(j) are patient-cluster spe-
ciﬁc random effects that represent the cluster centers and induce correlation between
genes in the same cluster. We assume cik(j)  N(0;2) after the data have been log-
transformed and centered to have mean zero. We also assume that cik and cik0 are
independent for k 6= k0. Thus, for a given patient, the covariance between genes in the
same cluster is 2 while genes in different clusters and across different patients remain
independent. The ij are measurement errors, assumed to be distributed N(0;2). To
link the gene clusters to patient outcome, we specify a linear relationship between the
clusters and Zi, a continuous outcome for patient i,
Zi =
K X
k=1
kcik(j) + i: (1.2)
The cluster effects relate gene expression and patient outcome to each other by acting
as covariates in the regression model. The k are the respective regression coefﬁcients
for each cluster, and the error terms are assumed to be i  N(0;2).
Latent variables  = (11;:::;1K;21;:::;JK) are introduced into the model, where
6jk is an indicator denoting membership of gene j in cluster k. Additionally, let ! =
(!1;:::;!K) be the cluster weights with !k > 0 for all k and
P
k
!k = 1. These weights
represent the probability of belonging in each cluster.
1.2.2 Joint Likelihood
We will work with the marginal likelihood where the random effects c are integrated
out:
f(Y;Zj;;;;;!) =
Z
f(Y;Zjc;;;;;;!)f(cj)dc: (1.3)
This is for ease of computation, since the random effects are nuisance parameters and
our model ﬁtting procedure is facilitated by not having to estimate all of them. A
closed form expression for (1.3) is readily achieved, as described next, because the
random effects are normally distributed.
Let Xi = (Yi;Zi), the vector of observations associated with patient i, where Yi =
(Yi1;:::;YiJ). Let  denote the set of parameters f;;;;;!g. The resulting complete
data likelihood for (Y;Z) is given by a multivariate normal distribution,
f(Y;Zj) =
N Y
i=1
expf 1
2X0
i 1Xig
(2)(J+1)=2jj1=2 :
The covariance matrix  is a symmetric (J + 1)  (J + 1) matrix that is block diagonal
in all but the last row and column. It is represented by
u;v = 2I(u = v) + 2
K P
k=1
I(u;v 2 Sk)
u;J+1 = 2
K P
k=1
I(u 2 Sk)k
J+1;J+1 = 2
K P
k=1
2
k + 2
(1.4)
where the subscripts index the matrix elements. Here, u = (1;:::;J);v = (1;:::;J),
and Sk denotes the kth cluster set.
7A closed form expression exists for both the inverse and determinant of . Therefore,
the expression for the multivariate normal distribution simpliﬁes substantially, speed-
ing up computation of the Metropolis-Hastings algorithm.
1.2.3 Prior Distributions for Model Parameters
We specify a non-informative prior distribution for every parameter. The prior for 
is set to be uniform on a wide range. We also specify a uniform prior on a wide range
for the hierarchical parameter , as recommended by Gelman (2006). The standard
non-informative prior is used for the regression parameters (;2) / 1/2.
Non-informative conjugate priors are speciﬁed for ! and . A symmetric Dirichlet
prior is set for the weights, P(!1;:::;!K) / Dirichlet(;:::;). Larger values of 
reﬂect the presence of more clusters, while smaller values of  reﬂect fewer clusters.
Lastly, the cluster membership variable  has a multinomial prior that depends on the
weights, P(jk = 1) = !k.
1.2.4 MCMC Clustering Algorithm
We ﬁt the model by implementing a MCMC algorithm that consecutively samples ev-
ery parameter until a sufﬁcient representation of the posterior distribution is achieved.
The MCMC sampling procedure consists of repeating the following six steps until con-
vergence:
1. Sample 2.
2. Sample 2.
3. Sample .
4. Sample !.
85. Sample .
6. Sample 2.
Gibbs sampling is used for sampling the parameters that have an available full condi-
tional posterior distribution. The set of samples obtained through multiple iterations
estimates the posterior distribution of that parameter. When the full conditional dis-
tribution cannot be directly sampled from, we use the Metropolis-Hastings algorithm.
Candidate values are drawn from a proposal distribution and accepted with probabil-
ity proportional to the ratio of the posterior density evaluated at the current value to
the posterior density evaluated at the new value. That is, samples are accepted with
probability
min(1;
P(jY;Z)=Q(j0)
P(0jY;Z)=Q(0j)
)
where Q is the proposal density, P is the posterior likelihood, 0 is the current parame-
ter value, and  is the candidate parameter value.
Update of variance parameters
The Metropolis-Hastings algorithm is used to sample 2;2, and 2. We use an in-
verse gamma proposal distribution with shape parameter s and scale parameter s=.
These tuning parameters are determined experimentally during initial runs to accept
proposed samples at the recommended rate of 40%   45% (Gelman et al., 2004).
Update of cluster membership and weights
Cluster membership  is sampled from a multinomial distribution with probabilities
proportional to the likelihood given the current parameter values. For every gene,
we calculate the likelihood of belonging in each of the K clusters. The value of the
likelihood weighted by the current value of ! then becomes the updated multinomial
9samplingprobabilities. Wesampledirectlyfromthefullconditionaldistribution, given
by
f(jjY;Z;;;;;!) /
K Y
k=1
(f(Y;Zj;;;;!)  !k)
jk:
After sampling the cluster memberships of all the genes, ! is sampled via a Gibbs step.
The full conditional distribution of ! is Dirichlet( + n1;:::; + nK), where nk is the
current number of genes in the kth cluster.
Update of regression coefﬁcients
The regression coefﬁcients  are sampled as a block by a Metropolis-Hastings algo-
rithm. We specify a multivariate normal proposal distribution with an independent
mean that is continuously updated whenever j is updated in step 3. When a gene
is assigned to a different cluster, the average of the coefﬁcients of the original cluster
and the new cluster become the new coefﬁcients for the respective clusters. The re-
sulting value after updating all the j is then used as the proposal mean. As for the
proposal covariance, we found through initial experimental runs that a covariance of
0.2*I,whereIistheidentitymatrix, producesanacceptancerateneartherecommended
rate of 20%   25%.
1.2.5 Model Without Outcome
The random effects clustering model in (1.1) can stand alone as a special case of the full
joint model. In this simple case, f(Y j;;;!) is a multivariate normal density with
covariance matrix equal to (1.4) with the last row and column removed. Simplifying
the likelihood expression leads to
f(Y j;;;!) =
expf 1
2
N P
i=1
[ 2
K P
k=1
(
P
j2Sk
(Y 2
ij)   2
2+nk2(
P
j2Sk
Yij)2)]g
[(2)J(2)J K
K Q
k=1
(2 + nk2)]N=2
:
10Estimates of the unknown parameters are obtained by Metropolis-Hastings sampling
in the same manner as previously described. We found that the random effects model
does in fact cluster genes differently from the ﬁxed effects model. To illustrate ana-
lytically, we make the simplifying assumption that there is an equal number of genes
in every cluster and derive an expression for the log-likelihood that has the variance
components proﬁled out. As expected, the proﬁle log-likelihood for the ﬁxed effects
model is maximized when each gene is as close as possible to its cluster center,
L /
X
i
X
k
X
j2Sk
(Yij   Y ik)
2:
Interestingly, for the random effects model,
L /
X
i
X
k
X
j2Sk
(Yij   Y ik)
2  n
X
i
X
k
(Y ik)
2:
This result implies that genes are clustered in a way that not only minimizes the dis-
tance to the cluster centers, but also shrinks the cluster means towards zero.
1.2.6 Determining the Number of Clusters
Though the true number of non-empty clusters is unknown, it does not need to be
sampled separately in our algorithm because an estimate of K is obtained at every
iteration as an immediate result from the samples of cluster membership. Recall that
P(jk = 1) is proportional to the weighted likelihood of belonging in cluster k. These
multinomialprobabilitiesarealwaysnon-zerobecause!k ispositiveforallk regardless
of cluster size. Due to the probabilistic nature of the allocation, there is always a chance
that a cluster will end up with no genes, or that an empty cluster will become ﬁlled at
any given iteration. Therefore, the only value that needs to be speciﬁed in advance
is Kmax, the maximum number of clusters. Kmax can also be thought of as the total
number of both empty and non-empty clusters, where 0  K  Kmax.
111.2.7 Posterior Inference
Posterior Distributions
The MCMC algorithm outputs samples from the posterior distribution of each of the
parameters and can be characterized by its posterior mean and posterior credible in-
terval. We make an exception for  and instead summarize its posterior distribution
by the concordance between every pair of genes, where concordance is measured as
the percentage of iterations that a pair of genes falls into the same cluster. Displaying
cluster membership as a heat map allows the relationship between genes to be cap-
tured and circumvents the issue of label switching which can cause the appearance
of non-identiﬁability. The other cluster-dependent parameters,  and !, can also ap-
pear non-identiﬁable as a consequence of label switching. A remedy is to index these
parameters by genes rather than by clusters.
Prediction
Given microarray data for a new patient, the predictive density of that patient’s out-
come can be obtained. Since Zi and Yi are both normally distributed, f(ZijYi) is also
normally distributed. Its expected value and variance are given by
E(ZijYi) = 
2
K X
k=1
k
2 + nk2(
X
j2Sk
Yij)
V ar(ZijYi) = 
2
2
K X
k=1
2
k
2 + nk2 + 
2:
This distribution allows us to estimate the expected value of a future patient’s outcome
based on their expression values.
121.3 Simulations
Simulationswereconductedtoevaluatetheperformanceofouralgorithmandtostudy
the effect of outcome inclusion and different parameter values on the resulting clusters.
In the ﬁrst simulation study, we generated 100 datasets under the model without out-
come and 100 datasets under the model with outcome. Each set of data consisted of
80 patients and 50 genes arising from 5 clusters. We considered various values of 2
to assess the ability of our method to detect the correct cluster structure when cluster
variation is low and when cluster variation is high compared to the variation in the
residual error. This ratio, 2=2, is what we will refer to as the variance ratio. The re-
maining parameter values were set to  = 1; = 1;1 =  3;2 =  1;3 = 2;4 = 3;
and 5 = 5. We set  = 1 for the Dirichlet prior and Kmax = 10. For every dataset, we
ran 10,000 iterations and discarded 5,000 as burn-in.
A visual representation of the simulation results is presented in Figure 1.1. Cluster
membership is depicted as a heat map that shows the proportion of iterations that
every pair of genes is assigned to the same cluster. In the event of label switching,
summarizing the output as a heat map aids in visualizing the groups, but even in
the absence of label switching, the heat map has the advantage of providing informa-
tion about the uncertainty surrounding the allocations. We do not assume that  is a
ﬁxed value, but rather a parameter with a distribution where some groupings are more
likely than others. Heat maps for the models with and without outcome are shown for
2=2 = 4 and 2=2 = 0:2 . The genes are listed along both axes in the same order,
grouped together by their true cluster membership. Concordance is represented as a
gradient from white (0%) to red (100%) with 16 discrete shades of color.
As depicted in the heat maps in Figure 1.1, the clustering is very clear when the vari-
ance ratio is large regardless if outcome information is used. On the other hand, we
observe a weak signal when the variance ratio is small. However, the clusters become
more well-deﬁned when outcome is introduced into the model.
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Figure 1.1: Cluster heat maps for simulated data. Concordance varies from 0% (white)
to 100% (red).
14Table 1.1: Parameter estimates resulting from simulation for the model with and with-
out outcome with N=80 patients, J=50 genes, and 100 replications with 5000 iterations
each.
True value Mean SE Mean of SE
With outcome
 1 0.993 0.012 0.012
 2 1.768 0.079 0.065
1 -3 -3.824 2.039 1.499
2 -1 -1.674 2.623 1.893
3 2 1.425 3.107 2.286
4 3 2.483 3.189 2.285
5 5 4.520 3.389 2.479
Without outcome
 1 0.993 0.012 0.012
 2 1.780 0.079 0.065
Table 1.1 displays posterior summary statistics of the parameters that result from the
simulation when the variance ratio is large. We see that they are all well estimated
by the MCMC algorithm. Note that estimation of the k only makes sense when the
algorithm has converged to a stable pattern and is conditional on K = 5 in the current
case. When there is substantial uncertainty in the clustering output, it is not possible
to report averaged values for k because there are different sets of k associated with
different values of K. However, when the majority of the genes cluster in the same way
across iterations, we can restrict ourselves to those iterations that estimated 5 clusters
and expect that the averages are reasonable estimates of the true value.
A second simulation study was conducted to understand the effect of the variance
ratio on cluster uncertainty. Uncertainty is deﬁned as the frequency of pairwise clus-
tering inaccuracies as compared to the true cluster pattern. For this we considered a
small dataset with 15 patients and 6 genes arising from 3 clusters with every two genes
belonging to the same cluster. We varied 2 to range from 0.5 to 7, while the other pa-
rameters were ﬁxed at  = 1; = 1;1 =  2;2 = 1; and 3 = 3. For every case, 10,000
15iterations were run with half discarded as burn-in. The model was ﬁt both with and
without outcome, and uncertainty was calculated for the range of variance ratios. The
results are plotted in Figure 1.2. Given the described clustering pattern, the maximum
amount of uncertainty that can be attained is 0.33. As 2=2 increases, the uncertainty
decreases towards zero and we see that clustering with outcome consistently produces
less uncertainty than clustering without outcome.
When the clustering signal is strong, that is when 2 is large, the clustering parameter
tends to converge quickly to the correct answer. Though this is advantageous, the
drawbackisthattheclusteringparameterdoesnotmixaswellasonewouldhope. This
is because our algorithm only considers moves of one gene at a time, so the likelihood
tends to not change enough to accept reallocations of a single gene. Nevertheless, there
is no apparent need to over-explore the partition space when there is a strong signal
because we still obtain convergence to the right clustering pattern. On the other hand,
when the clustering signal is weak or nonexistent, mixing is irrelevant because the
algorithm cannot reach convergence anyways due to a weak signal. It is in the case
of a moderate signal that we would most want to see good mixing and hope that the
frequency of genes clustering together is reﬂective of the probability of belonging in
the same cluster. In the simulation setting, the lack of mixing in any given dataset is
circumvented by averaging across all the simulated datasets. This is effectively the
same as implementing several chains for every run and averaging across the chains,
which is what we proceed to do in the Glue Grant data analysis.
1.4 Application
We applied our methodology to the Inﬂammation and Host Response to Injury trauma
data, a rich dataset that contains information on numerous factors related to the biol-
ogy of inﬂammation following severe traumatic injury. There are a total of 167 patients
in the trauma dataset, each of whom has their blood leukocyte expression levels mea-
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Figure 1.2: Plot of cluster uncertainty with and without outcome for different variance
ratios.
17sured on an Affymetrix microarray chip consisting of 54,674 probe sets (which we will
henceforth call ‘genes’). The full dataset consists of microarrays that have been taken
at seven different time points following the patients’ injury, starting from immediately
after the injury to up to 28 days later. For our analysis however, we restrict ourselves
only to microarray data collected on day four from the 147 patients who are still in the
intensive-care unit at that time.
The gene expression values have been pre-processed using dChip, log-transformed
and centered prior to analysis. We use a subset of 87 genes for our cluster analysis.
These genes were pre-selected by Glue Grant investigators to be those that had signif-
icant differential expression with at least a two-fold difference between patients with
a clinical outcome of complicated versus uncomplicated recovery. Our objective is to
ﬁnd clusters of genes that are associated with each other as well as associated with a
relevant patient outcome. The outcome that we use in our analysis is maximum multi-
ple organ failure (MOF), a continuous score that describes the severity of the patient’s
multiple organ failure and is predictive of metabolic recovery. MOF is the cumula-
tive sum of individual scores from the respiratory, renal, hepatic, cardiovascular, and
hematologic components, each ranging in value from 0 to 4 for least to most severe.
The resulting groups of genes can then be examined for their functional relationships
and interdependent roles in the inﬂammation response pathway.
We ran ten MCMC chains, each starting from a different set of randomly chosen over-
dispersed starting values. Non-informative priors were speciﬁed for all the parame-
ters; hyper-parameters were chosen to be  = 1 and Kmax = 15. We evaluated mixing
and convergence by assessing the trace plots and observed that convergence occurred
fairly quickly. As mentioned previously, we ran multiple chains to simulate good mix-
ing and averaged across all chains. Thus, for each of the MCMC chains, we ran 10,000
iterations with 5,000 discarded as burn-in.
The heat map for clustering combined across chains for the model with and without
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19patient outcome is shown in Figure 1.3. The genes are listed along both axes in the
same order for both plots. When the model is ﬁt with outcome, the genes labeled 1-
58 fall into seven distinct clusters the majority of the time upon convergence. These
seven clusters are clearly distinguished by the red boxes along the diagonal starting
from the bottom-left with the exception of some orange overlap between genes labeled
42 to 58 on the plot. It appears that about 20% of the time, genes 57 and 58 form their
own cluster of size two, while the remainder of the time they are part of the larger
cluster. On the other hand, several breakdown combinations are observed for genes
59-87. They do not group into clear partitions, implying that several partitions have
similar posterior probabilities.
When we ﬁt the model without outcome, we obtain a heat map that appears compa-
rable though there is more pronounced uncertainty. The general partition structure
remains the same, but now there is more orange and yellow in some groups because
the posterior pairwise probabilities are not as high. There are various subsets of genes
that form their own clusters on occasion. The only genes for which there is actually
less uncertainty are genes 85-87, as they now exclusively cluster together.
In both cases, clusters consisting of only one gene are allowed. Normally we may not
wish to have singletons for a dataset that has thousands of genes, but since this is a
fairly small subset of genes that was pre-selected to be important, we do not want to
be too strict in forcing singletons into larger sized clusters.
A summary of the output is shown in Table 1.2. The mean of the variance ratio is
3.22 for the case with outcome and 3.51 for the case without outcome. The uncertainty
surrounding cluster membership is minimal because the estimated variance ratio is
relatively large. The coefﬁcient estimates are conditional on K = 10, where the clusters
are of size 1, 1, 2, 3, 10, 24, 17, 1, 25, and 3 (from left to right in Figure 1.3). Only those
iterations for which the genes in each respective cluster exclusively group together are
used in calculating the coefﬁcient estimate for that cluster.
20Table 1.2: Results of Glue Grant trauma data analysis with and without a continuous
outcome (maximum MOF score).
With outcome Without outcome
Mean 95% credible interval Mean 95% credible interval
 0.579 (0.563, 0.592) 0.564 (0.503, 0.587)
 1.039 (0.992, 1.085) 1.056 (1.009, 1.142)
1 0.239 (-0.625, 0.961) – –
2 0.179 (-0.499, 0.684) – –
3 -0.514 (-1.606, 0.030) – –
4 -0.356 (-1.523, 0.387) – –
5 0.436 (-3.363, 2.321) – –
6 -0.344 (-8.745, 3.443) – –
7 -0.653 (-6.512, 3.036) – –
8 0.629 (-0.363, 1.329) – –
9 -0.173 (-8.713, 5.110) – –
10 0.582 (-0.997, 1.273) – –
Figure 1.4 displays a heat map of the gene expression data that has been sorted ac-
cording to the clustering results. Every row is a patient, where the patients are sorted
by increasing MOF, and every column is a gene, where the genes are sorted by the
mean of the regression coefﬁcient of their respective clusters. Gene expression val-
ues have been centered at zero in both directions; red represents under-expression and
green represents over-expression. The cluster groupings are denoted by the brackets
along the bottom of the ﬁgure. As expected, different values of MOF are associated
with different gene expression patterns, and genes in the same cluster have similar ex-
pression patterns, Furthermore, clusters with a positive coefﬁcient have an opposite
pattern from clusters with a negative coefﬁcient. Cluster nine is the one exception.
Even though the mean of 9 is negative yet the pattern implies the opposite, its value
is very close to zero and suffers from high variability. Substantial cluster uncertainty
surrounding cluster nine accounts for its high coefﬁcient variability and expected in-
stability.
Lastly, the average prediction error was calculated by 5-fold cross-validation. The
mean-squared error (MSE) for our method is 4.78, while the MSE from partial least
217 3 4 6 9 2 1 5 10 8
Figure 1.4: Heat map of sorted gene expression data. Red represents under-expression
and green represents over-expression. The numbers correspond to the cluster labels in
Table 1.2.
22squares regression is 9.61 conditional on K=10. In addition to having a lower MSE, our
method fulﬁlls the additional purpose of providing interpretable gene clusters.
1.5 Discussion
We have proposed Bayesian methodology for the informative clustering of genes. Our
model accounts for correlation between genes in the same cluster and jointly relates
the gene expression values to a continuous patient outcome such that this additional
information helps drive the clustering of the genes.
It would be worthwhile to consider relaxing some of the assumptions of our model.
For example, a heterogeneous covariance structure where a different k is speciﬁed
for every cluster would allow for more ﬂexibility. A non-linear relationship between
the clusters and outcome could also be modeled. We mentioned some solutions to deal
with the mixing problem, but the best way to handle this issue would be to incorporate
global moves such as splitting or combining clusters. Though this would allow the
partitionspacetobeexploredmorefully, itwouldaddextracomputationalcomplexity.
Our model can be extended to accommodate categorical outcomes using a probit or
logistic model, or time to event outcomes using semi-parametric models. Additionally,
the model can be extended to the longitudinal microarray setting where it is assumed
that groups of genes cluster together in their patterns over time.
23Latent Variable Methods for Clustering Genes Using
Binary and Failure Time Outcome Data
Jessie J. Hsu, Dianne M. Finkelstein, and David A. Schoenfeld
Department of Biostatistics, Harvard School of Public Health
Biostatistics Center, Massachusetts General Hospital2.1 Introduction
The relationship between microarray data and binary patient outcomes is generally
framed as a classiﬁcation problem (Ring and Ross, 2002; Quackenbush, 2006). Gene
expression data can be highly predictive of clinical outcomes such as disease type, as
demonstrated in Golub et al. (1999). Microarrays can also be used to distinguish be-
tween different diseases. For example, Dudoit et al. (2002) compares nearest-neighbor
classiﬁers, linear discriminant analysis, and classiﬁcation trees for discriminating ma-
lignant versus normal tissue based on gene expression data in cancer patients. On the
other hand, modeling the relationship between gene expression and binary outcomes
using logistic regression can also lead to models that are highly descriptive of outcome.
The association between microarray data and survival outcomes can be studied in a
similar manner. Typically, the objective of these studies is to determine the hazard of
experiencing the event that is associated with the observed expression measurements.
Jung et al. (2005) and Gui and Li (2005) developed methods for identifying a subset
of genes that are biologically important and predictive markers of survival. In an ap-
proach suggested by Bair and Tibshirani (2004), each gene is given a Cox score based
on the proportional hazards partial likelihood and the top ranked ones are included in
a multivariate Cox model. A comprehensive overview of predicting patient survival
from microarray data is presented in Bøvelstad et al. (2007) and Wieringen et al. (2009).
Due to the high-dimensionality of microarray experiments, dimension reduction is of-
ten a necessary step in data analysis. Common methods for dimension reduction in-
clude principal component analysis and partial least squares, both of which reduce the
expression values to fewer dimensions based on correlation. If outcome information is
available, a supervised approach is generally preferred. Though these methods have
been extended to both binary and survival settings (Nguyen and Rocke, 2002; Park
et al., 2002), the drawback is they do not give interpretable components.
25We use clustering as a form of dimension reduction and as a way to gain insight into
underlying gene expression patterns. A standard cluster analysis involves a two-step
process where clustering is performed by a method such as K-means and the cluster
averages are used as covariates to model outcome. However, ideally we would like to
ﬁnd clusters and simultaneously predict outcome such that each part is inﬂuenced by
the other. To this end, the Bayesian approach for model ﬁtting is a natural way to allow
for outcome-driven clustering of gene expression data due to its iterative approach.
Previous Bayesian contributions in the realm of clustering multivariate data include
Booth et al. (2008) and Tadesse et al. (2005), both of whom use Markov chain Monte
Carlo (MCMC) methods for clustering data. For our contribution, we seek to use pa-
tient outcome to inform the discovery of gene clusters with the hope that the resulting
clusters provide a more coherent depiction of the underlying biological mechanism.
We propose a joint model that relates clusters of gene expression measurements to bi-
nary and event time outcomes. Our model for gene expression adds complexity to
standard mixture models (McLachlan et al., 2002) by incorporating cluster and subject
speciﬁc random effects. These random effects account for correlation between genes in
the same cluster and allow us to extend the mixture-model construction to the setting
where non-independent patient features are being clustered. For a binary outcome, the
probability of experiencing the event is related to the clusters via the introduction of la-
tent continuous variables into the model. The latent variables are then linearly related
to the cluster random effects which transforms the model into the standard linear re-
gression formulation. Conditional on the continuous latent response, the methodology
for estimating the posterior distribution of the parameters is equivalent to clustering
using a continuous outcome as described in Chapter 1. Obtaining these latent parame-
ters is readily achieved by adding an extra step into the MCMC sampling scheme (Al-
bert and Chib, 1993). An example of this type of Bayesian latent variable approach is
described in Sha et al. (2004). In their paper, they augment a probit model with contin-
uous latent variables to accommodate multinomial response variables for the purpose
26of high-dimensional variable selection. We extend our binary model to accommodate
survival data by treating time-to-recovery as a series of binary observations at a ﬁxed
number of discrete time points where the outcome at every time point is evaluated as a
binary response. Again, we augment the data by assuming that the hazard of the event
at any given time depends on a latent continuous variable. Then, a negative binomial
model with a constant hazard of recovery is assumed for describing the amount of time
that a patient is at risk.
Our method is applied to trauma data from the Inﬂammation and Host Response to
Injury Program. Also known as the Glue Grant, this research project is an interdisci-
plinary study of the biological changes that a patient goes through after experiencing
severe trauma injury. The data consists of expression values measured on thousands of
genes, as well as various clinical measurements and recovery endpoints for every pa-
tient. Utilizing patient recovery to drive the process of clustering genes can potentially
result in groups that more thoroughly capture the relationship between genes.
We proceed with a detailed description of the methodology in Section 2.2. The results
of simulations are shown in Section 2.3. An analysis of microarray data from the Glue
Grant is presented in Section 2.4, and we end with a discussion in Section 2.5.
2.2 Methods
2.2.1 Clustering Genes Using a Binary Outcome
For every subject i, i = 1;:::;N, we observe (Yi;Xi), where Yi is a vector of gene ex-
pression values and Xi is a single binary outcome. Our goal is to group the genes into
several clusters based on similarities in their expression values and their association to
the binary response. The genes should cluster in such a way that genes in the same
cluster are highly correlated with each other, while genes in different clusters are mu-
tually independent. Genes in the same cluster should also share a similar relationship
27to the response variable. In order to obtain clusters with these properties, we will ﬁt a
joint model that relates the gene expression values to the binary outcome.
The ﬁrst part of the joint model describes the observed gene expression data. We as-
sume that the dependence among genes in the same cluster is induced by subject and
cluster speciﬁc random effects. Thus, for gene j belonging in cluster k, the model for
gene expression is formulated as follows:
Yij = cik(j) + ij;cik(j)  N(0;
2);ij  N(0;
2) (2.1)
It can be shown that the presence of patient-cluster speciﬁc random effects in the
model, represented by cik(j), results in a covariance of 2 between genes in the same
cluster and a covariance of zero between genes in different clusters. We assume that cik
and cik0 are independent for k 6= k0. We also note that the reason that both the random
effects and the error terms have mean zero is because we assume the data have been
centered at zero for every patient and gene prior to analysis.
Though the random effects provide information about the relationship between genes
in different clusters, they provide no indication of the clustering pattern itself. It is
therefore necessary to introduce additional parameters into the model to represent the
unknown cluster membership. We use indicator variables jk to denote the member-
ship of gene j in cluster k. We assume the vector of indicators associated with each
gene has a multinomial distribution with probabilities !k, k = 1;:::;K, where !k > 0
8k and
P
k
!k = 1. The entire clustering pattern can then be obtained directly from the
matrix of cluster indicators.
The second part of the joint model describes the observed binary response. For every
patient i, Xi is a Bernoulli(p) distributed random variable that equals one if the patient
experienced the event. However, ﬁtting a model that has a Bernoulli distributed ran-
dom variable greatly increases the difﬁculty of implementing a MCMC because none
of the posterior distributions are tractable. Therefore we facilitate the Bayesian model
ﬁtting procedure by introducing a normally distributed latent variable Zi that will be
28simulated by MCMC and assume that the probability associated with Xi depends on
Zi. Known as the data augmentation approach (Tanner and Wong, 1987), Zi can be
thought of as an unmeasured underlying process that directly determines the value of
the observed binary response Xi. Augmenting the data to include Zi requires the spec-
iﬁcation of a function that links the relationship between Xi and Zi (Albert and Chib,
1993). In the context of data augmentation, the probit link is most commonly used:
P(Xi = 1) = (Zi) (2.2)
where  is the cumulative density function of the standard normal distribution. The
dependence of Xi on Zi is straightforward; a smaller value of Zi implies that Xi is more
likely to be zero and a larger value of Zi implies that Xi is more likely to be one.
Up to this point, we have proposed separate models for the clusters of gene expres-
sion data and for the binary outcome. The ﬁnal layer of the model is to connect these
two components together. The gene clusters are related to the binary outcome by a
linear relationship between the cluster random effects and Zi, the continuous latent
representation of the binary response:
Zi =  +
K X
k=1
kcik(j): (2.3)
This is essentially a linear regression model where the k act as coefﬁcients that de-
scribe the effect of the cluster centers on the continuous latent outcome.
We noticed that when  was unconstrained, it tended to increase without bound. The
reason this model may not converge is because we only observe Xi and have fewer
degrees of freedom than provided by the normal model. We found that convergence
occurs when  is constrained to lie on the unit sphere such that T = 1. A convenient
distribution for points on a sphere is the von Mises-Fisher distribution, which we detail
in Section 2.2.2.
29Prior Distributions
Non-informative prior distributions are speciﬁed for every parameter. The priors for
the hierarchical standard deviation components  and  are uniform densities on a
wide range. This is approximately equivalent to specifying an Inverse-2 prior distri-
bution on 2 and 2. For the vector of cluster probabilities !, we specify a conjugate
symmetric Dirichlet(;:::;) prior. Smaller values of  reﬂect a prior belief that there
should be fewer clusters and larger values drive the clustering towards more clusters.
The cluster membership variable has a conjugate multinomial prior that depends on
the weights, P(jk = 1) = !k. The intercept term  is given a non-informative uniform
prior, and a von Mises-Fisher prior distribution with concentration parameter  = 0 is
speciﬁed for the vector . This parameter setting is non-informative and is equivalent
to uniformity on a K-dimensional unit sphere.
2.2.2 MCMC Clustering Algorithm
TheMCMCalgorithmiteratesbetweendrawsfromthefullconditionalposteriordistri-
butions f(ZijYi;Xi;) for every patient i and f(jY;X;Z), where  denotes the entire
set of parameters f;;;;;!g. We exclude the random effects c from the parameter
set because we will only be working with distributions that have the random effects
integrated out so that they no longer appear in the likelihood. Carrying out this math-
ematical detail greatly reduces the dimension of the parameter space and increases the
stability of the algorithm.
To sample Zi, write
f(ZijYi;Xi;)
/ f(XijZi;Yi;)f(ZijYi;)
= [(Zi)I(Xi = 1) + ( Zi)I(Xi = 0)](ZijYi;;
2
ZijYi;): (2.4)
Since both Zi and Yi are normally distributed, f(ZijYi;) is readily available as a con-
30ditional normal distribution with mean ZijYi; =  + 2
K P
k=1
(k=(2 + nk2))(
P
j2Sk
Yij)
and 2
ZijYi; = 22
K P
k=1
2
k=(2 + nk2).
Due to the difﬁculty of drawing Zi directly from (2.4), we utilize the acceptance-
rejection algorithm for sampling Zi. The acceptance-rejection algorithm for simulating
random variables with density f() operates by ﬁnding a density g() from which it
is easy simulate, along with a constant M such that f()=g()  M 8. The algorithm
proceeds by simulating values  from f() and accepting these values with probability
f()=(Mg()). As a result, the elements in the set of values that are accepted will be
random variables from f().
In our case, f() is the expression in (2.4). If we let g() = (ZijYi;;2
ZijYi;), then M = 1
is an upper bound. Since Z1;:::;ZN are independent random variables, the steps in the
algorithm are as follows:
1. Generate Z
i  (ZijYi;;2
ZijYi;).
2. Generate U  Uniform(0;1).
3. If U < [(Zi)I(Xi = 1) + ( Zi)I(Xi = 0)], then accept Z
i ; otherwise, reject Z
i .
Next, we need to sample from f(jY;X;Z). Conditional on Z and Y , it is not neces-
sary to also condition on X because X gives no additional information given Z. To
simulate any single parameter  from the set , we write the full conditional posterior
distribution for :
f(jY;Z; ) / f(Y;Zj)f(): (2.5)
Note that f(Y;Zj) is a product across independent patients i, where f(Yi;Zij) is
multivariate normal with mean (0;:::;0;)0 and covariance , a symmetric (J +1)(J +
311) matrix that is block diagonal in all but the last row and column:
u;v = 2I(u = v) + 2
K P
k=1
I(u;v 2 Sk)
u;J+1 = 2
K P
k=1
I(u 2 Sk)k
J+1;J+1 = 2
K P
k=1
2
k
where u = (1;:::;J) and v = (1;:::;J) index the matrix elements, and Sk denotes
the kth cluster set. The expression for the multivariate normal distribution simpliﬁes
substantially because a closed form expression exists for both the inverse and the de-
terminant of .
If the distribution represented by (2.5) is available in closed form for any given pa-
rameter, basic Gibbs sampling is used and samples are drawn directly from the closed
form distribution. If the full conditional posterior cannot be sampled from directly,
we utilize the Metropolis-Hastings algorithm, where candidate values are drawn from
a proposal distribution and accepted with probability proportional to the ratio of the
posterior density evaluated at the current value to the posterior density evaluated at
the new value. More explicitly, supposing that 0 is the current parameter value and 
is the candidate value, samples are accepted with probability
min(1;
P(jY;Z)=Q(j0)
P(0jY;Z)=Q(0j)
)
where Q is the proposal density and P is the posterior likelihood.
Using the theory presented above, we continue describing the details of sampling
each parameter in . To simulate the variance parameters 2 and 2, the Metropolis-
Hastings algorithm is used. We draw candidate values from an inverse gamma pro-
posal distribution with shape parameter s and scale parameter s=. These tuning pa-
rameters are determined experimentally during initial runs to accept proposed sam-
ples at the recommended rate of 40%   45% (Gelman, 2006).
The probabilities associated with belonging in each cluster are sampled via a Gibbs
step. The full conditional distribution of ! is Dirichlet(+n1;:::;+nK), where nk is the
32number of genes in the kth cluster at the current iteration. We found that setting  = 1
provides a reasonable result. The cluster membership of each gene, j, is sampled from
a multinomial distribution with probabilities proportional to the weighted likelihood
given the current parameter values. The clustering space is explored in a stochastic
search where each gene is moved into every cluster and the likelihood of belonging in
each of the K clusters is calculated. The value of the likelihood weighted by the current
value of ! then becomes the updated multinomial sampling probabilities.
The intercept term  is sampled using Metropolis-Hastings. Candidate values are
drawn from a normal proposal distribution with variance equal to one. The vector
of coefﬁcients, , is obtained by Metropolis-Hastings sampling as well. As mentioned
earlier, we constrain  to exist on the K-sphere such that the sum of squares equals one.
The von Mises-Fisher (vMF) distribution for a unit vector of dimension K has proba-
bility density function f(x) = CK()exp(Tx) and is suitable for drawing candidate
values with the desired constraint. Here, C is a constant,   0 is the concentration
parameter, and  is the mean direction. Following the steps described in Wood (1994)
on how to sample from the vMF distribution, the result is a K-dimensional unit vector
with modal direction (0;:::;0;1)T and concentration parameter . Applying QR de-
composition rotates the vector such that the modal direction is located at the proposed
value of .
2.2.3 Extension to Failure Time Outcome
Our proposed hierarchical model can be extended to time-to-event outcomes in a
straightforward manner. We represent time-to-event as an indicator variable that is
a function of time, Xi(t). If patient i experiences an event at time t, then Xi(t) = 1;
otherwise if the patient has not yet had the event by time t, then Xi(t) = 0. Rather
than observing a single binary endpoint, we now observe a vector of binary responses
for every patient with one response at every time point. The responses are recorded at
33ﬁxed discrete time points until the patient is no longer in the risk set.
As in the case with a binary outcome, we utilize the data augmentation approach and
introducelatentvariablesZi intothemodel, whereZi isnormallydistributedandmod-
eled as shown in (2.3). Let Li be the number of times that patient i is evaluated for hav-
ing the event. The hazard of the event at any particular time tl;l = 1;:::;Li, depends
on Zi as follows:
P(Xi(tl) = 1jXi(tl 1) = 0) = (Zi): (2.6)
Forthepurposesofillustratingourmethod, weassumethateachpatienthasaconstant
underlying hazard of experiencing the event. However, this assumption can be relaxed
to accommodate non-constant hazards with the inclusion of an additional parameter
per time point. To model the amount of time that a patient is in the risk set, we assume
a negative binomial distribution where the probability of success is simply the hazard
of recovery as shown in (2.6). The probability of recovering at the lth time point then
becomes ( Zi)l 1(Zi).
The MCMC for ﬁtting the survival model follows almost exactly the same steps as
in the case of the binary outcome. The only difference occurs in step three of the
acceptance-rejection algorithm because the full conditional posterior distribution of Zi
is now a product across the time points:
f(ZijYi;Xi;)
/ f(XijZi;Yi;)f(ZijYi;)
=
Li Y
l=1
[(Zi)I(Xi(tl) = 1) + ( Zi)I(Xi(tl) = 0)](ZijYi;;
2
ZijYi;): (2.7)
Therefore we have the same function g() and the same constant M = 1, but ac-
ceptance of Z
i is now based on a comparison of the uniform random variable to
Li Q
l=1
[(Zi)I(Xi(tl) = 1) + ( Zi)I(Xi(tl) = 0)].
342.3 Simulations
We conducted simulations to compare the effect of using an informative outcome
against a non-informative outcome. For both, expression data was generated under
the proposed model with ﬁxed parameter values. In particular, we point out that we
set  = 0:5 and  = 1, which represents a fairly small amount of variability between
the clusters compared to the residual variance. Non-related event outcomes were ob-
tained by generating outcomes at random for every patient. We simulated 50 datasets
for both informative and non-informative binary and failure time outcomes. Each set
of data consisted of 80 patients and 50 genes arising from 5 clusters. For every dataset,
we ran 5000 iterations and discarded 2000 as burn-in.
The cluster heat maps for the simulated data are presented in Figures 2.1 and 2.2. In
both ﬁgures, having a non-informative outcome produces more uncertainty, where un-
certainty is deﬁned as the frequency of pairwise clustering inaccuracies as compared to
thetrueclusterpattern. Giventhedescribedclusteringpattern, randomnoiseproduces
an uncertainty of 0.206. The uncertainties for an informative and non-informative bi-
nary outcome are 0.042 and 0.068, respectively. The uncertainties for an informative
and non-informative survival outcome are 0.043 and 0.047, respectively.
2.4 Application
The Glue Grant dataset contains information on numerous factors related to the bi-
ology of inﬂammation following severe traumatic injury. Data on 147 subjects are
included in the analysis, each of whom has their blood leukocyte expression levels
measured on an Affymetrix microarray chip consisting of 54,674 probe sets (which we
henceforth call ‘genes’). Arrays collected on day 4 following trauma will be used for
the analysis, the reason being that allowing a few days to pass after the event will give
expression levels that are more differentiated and thus more predictive of outcome.
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Figure 2.1: Cluster heat maps for simulated data with a non-informative and informa-
tive binary outcome.
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Figure 2.2: Cluster heat maps for simulated data with a non-informative and informa-
tive survival outcome.
36Table 2.1: Results of Glue Grant trauma data analysis with a binary outcome (compli-
cated vs. uncomplicated recovery) and survival outcome (time to recovery).
Binary outcome Survival outcome
Mean 95% credible interval Mean 95% credible interval
 0.372 (0.356, 0.388) 0.381 (0.368, 0.395)
 0.687 (0.660, 0.716) 0.690 (0.661, 0.723)
 0.929 (0.569, 1.306) -1.382 (-1.583, -1.184)
The gene expression values have been pre-processed using dChip, log-transformed
and centered prior to analysis. We use a subset of 87 genes for our cluster analysis that
have been pre-selected by Glue investigators to be those that had signiﬁcant differen-
tial expression with at least a two-fold difference between patients with complicated
versus uncomplicated recovery. Complicated recovery implies the patient had a time
to recovery of more than 14 days, and patients with an uncomplicated status recovered
in less than 14 days.
For both the binary and survival analyses, we ran eight chains with over-dispersed
starting values. We ran 8000 iterations until convergence and discarded 2000 itera-
tions as burn-in. The maximum number of clusters was set to be 15. For our method,
we only need to specify the maximum number of clusters and not the exact number
because our algorithm allows for empty clusters when the genes are tested for mem-
bership against every cluster. However, since we only make single gene transitions
when sampling cluster membership, there is a tendency to under-explore the parti-
tion space. Therefore, several chains at different starting values were implemented
and subsequently averaged for purposes of inference. Estimates of the parameters are
shown in Table 2.1.
We deﬁne the event of interest to be complicated versus uncomplicated recovery class
for the binary outcome. For the survival outcome, the response measurement is time
to recovery from trauma. Patients are followed for 28 days, and time to recovery is
calculated as the maximum time to cardiovascular, hematologic, hepatic, renal, or res-
37piratory recovery. We assume that recovery can only occur once for every patient and
that once recovery has occurred, the patient is no longer at risk. Recovery is the only
absorbing state in the model; once a patient recovers, the patient is considered to have
reached the end of the study. If patients do not recover during the course of the study
or if they die prior to the last observed day, they are censored on day 28 and have an
observed indicator vector that consists of all zeroes. Since only ﬁve of the 147 subjects
died from their injuries, mortality was not considered an appropriately sensitive vari-
able for informing distinct clusters. In addition to the ﬁve patients who died within
the ﬁrst 28 days, seven patients did not recover within the ﬁrst 28 days. Both of these
groups of patients are censored at 28 days since it is evident that none of these patients
will recover by day 28.
A visual representation of clustering with and without outcome is presented in Fig-
ure 2.3. Cluster membership is depicted as a heat map that shows the proportion of
iterations that every pair of genes was assigned to the same cluster. The similarity, or
concordance, between two genes is deﬁned as the percentage of iterations that they are
assigned to the same cluster. Concordance is depicted by a color gradient and ranges
from 0% (white) to 100% (red). By representing the cluster results in a heat map, la-
bel switching is accounted for and the allocation frequencies can be visualized clearly.
In all three heat maps, the genes are aligned in the same order along both axes. The
resulting partitions from using a binary outcome and from using a survival outcome
appear similar to each other. Slightly different groups are found when clustering with-
out outcome.
2.5 Discussion
In this chapter, we have developed methodology for using binary and failure time out-
comes to inform the clustering of gene expression data. The intention is primarily for
exploratory purposes, though the method can also be used for prediction. The clusters
382
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39can act as prognostic markers in predicting recovery among trauma patients, making
it possible to determine the posterior predictive probability that a future patient will
experience the event. By augmenting the data with latent continuous variables, we are
able to utilize the methods developed in Chapter 1. When applied to the Glue Grant
data, we can determine the probability that a pair of genes are in the same cluster and
identify groups of genes that tend to cluster together. Our approach does not require
speciﬁcation of the exact number of clusters and is also adaptable to situations where
there are more genes than subjects.
A limitation we foresee is that a more comprehensive stochastic search may be neces-
sary to fully explore the partition space. Implementing a reversible-jump MCMC, or
adding steps where sets of genes are combined and removed, may improve the mixing
of cluster membership. Several extensions of our methodology are possible as well.
The latent variable approach can be extended to accommodate multinomial outcomes
by allowing the response to take on more categories. Currently, our survival model
assumes a stationary process where the chance of recovery at every time point is in-
dependent of how long the patient has already been in the hospital. Our model can
be thought of as a discrete analog to the exponential distribution. We can extend our
survival method to have non-constant hazards by specifying a different parameter for
each time. For example, indexing the intercept by time would allow for a different
hazard at every time point and would provide additional ﬂexibility to the model.
40Outcome-Driven Clustering of Longitudinal Gene
Expression Data
Jessie J. Hsu, Dianne M. Finkelstein, and David A. Schoenfeld
Department of Biostatistics, Harvard School of Public Health
Biostatistics Center, Massachusetts General Hospital3.1 Introduction
Conducting microarray experiments has become standard procedure in the biological
sciences. Each experiment generates expression data on tens of thousands of genes
and is often repeated several times under different experimental conditions, further
increasing the dimensionality of the data. Reducing the dimension of longitudinal mi-
croarrays through clustering can elucidate underlying disease mechanisms and path-
ways. We will present a way to cluster high-dimensional longitudinal gene expression
data that utilizes clinical outcomes to drive the clustering.
Analyzingtheentiretime-coursegeneexpressionisappealingbecausegeneexpression
is naturally a temporal process that is constantly regulated and changing. However,
methods relating to baseline microarrays do not translate directly to longitudinal set-
tings because they do not capture the time course patterns and the ordered nature of
the time index (Bar-Joseph, 2004). The key to analyzing longitudinal genes is to spec-
ify a model for the time-dependent gene expression trajectory. Ramoni et al. (2002)
modeled the correlation between successive measurements of the same gene with au-
toregressive equations. Luan (2003) modeled the trajectory using splines, suggesting
that the ﬂexibility of splines can account for non-linear relationships between genes at
different time points and for data measured at unevenly spaced time intervals. More
recently, methods have been developed for modeling longitudinal gene expression
data using random effects in order to select differentially expressed time-course genes
(Storey et al., 2005; Rajicic et al., 2006).
Clustering longitudinal gene expression is based on the idea that similar temporal
proﬁles are involved in similar biological processes. Standard distance-based cluster-
ing methods assume observations of each gene are independent and identically dis-
tributed. For example, K-means clustering treats the input as a vector of independent
samples. This is inappropriate for clustering longitudinal data because it does not
account for correlation between successive observations of the same gene nor does
42it account for correlation between genes in the same cluster. Normal mixture mod-
els are also too simplistic for describing time-course dynamics (McLachlan et al., 2002).
Booth et al. (2008) and Ng et al. (2006) presented solutions for clustering correlated gene
expression proﬁles by proposing models with random effects that are shared among
correlated measurements of expression on the same gene and among gene expressions
from the same cluster.
For our contribution, we seek to use patient outcome to inform the discovery of gene
clusters with the hope that the resulting clusters provide a more coherent depiction of
the underlying biological mechanism. The scenario of clustering with a normally dis-
tributed continuous outcome was considered in Chapter 1. Here, we extend our pre-
vious methodology to the longitudinal microarray setting with binary and failure time
outcomes. To accommodate longitudinal measurements, we build upon the random-
effects model described in Rajicic et al. (2006) and assume a linear gene trajectory by
including a random intercept and a random slope for time. These random effects in-
duce correlation between genes in the same cluster, and the random slope captures the
relationship between repeated observations of the same gene over time.
The other challenge that we will deal with is the issue of specifying the relationship
between the non-continuous outcome and the longitudinal expression data. The rela-
tionship between binary outcomes and baseline gene expression data has been thor-
oughly studied and is usually framed as a classiﬁcation problem (Ring and Ross, 2002;
Quackenbush, 2006; Hastie et al., 2001a). The association between baseline microarray
data and survival outcomes can be studied in a similar manner and is usually modeled
using a Cox proportional hazards model. Typically, the objective of these studies is to
determine the risk of experiencing the event that is associated with the observed gene
expression measurements (Bøvelstad et al., 2007; Wieringen et al., 2009).
Despite established methods for analyzing binary and survival data, these models be-
come difﬁcult to ﬁt when considered jointly with clustering longitudinal microarrays.
43Sha et al. (2004) considers a similar situation of relating genes to categorical outcome
variables in order to identify differentially expressed genes. They followed the meth-
ods developed in Albert and Chib (1993) and augmented the data with a latent con-
tinuous representation of the outcome. They speciﬁed that the probability of having
the outcome depends on the latent variable which is sampled by Markov chain Monte
Carlo (MCMC) methods. We adopt this approach as well because having the latent
variable simpliﬁes the model ﬁtting procedure and allows us to apply the MCMC clus-
tering algorithm presented in Chapter 1.
In Section 3.2, we begin by summarizing the previous chapters. In Sections 3.2.1
and 3.2.2, we present the model for clustering longitudinal microarrays and the binary
response model. All the model parameters are assigned non-informative prior distri-
butions in Sections 3.2.3, and Section 3.2.4 describes how each of the model parameters
is sampled and how the clusters are found by the MCMC algorithm. An important
aspect of this is the number of clusters which is discussed in Section 3.2.5. We expand
our model to accommodate failure time outcomes in Section 3.2.6. In Section 3.3, we
illustrate our clustering method using trauma data from the Inﬂammation and Host
Response to Injury Program. We end with a discussion in Section 3.4.
3.2 Methods
We aim to cluster longitudinal gene expression data into several groups based on sim-
ilarities in their expression trajectories and their association to binary and failure time
outcomes. We build upon the methods proposed in Chapters 1 and 2. Chapter 1 al-
lowed for a continuous outcome to drive the clustering of baseline microarray data and
modeled gene expression with patient-cluster speciﬁc random effects that accounted
for correlation between genes in the same cluster. In Chapter 2, we considered binary
and failure time outcomes to drive the clustering of baseline arrays. A novel aspect of
our previous methodology is that the random effects do not need to be estimated be-
44cause we integrate over them such that they no longer appear in the likelihood. In this
chapter, we continue to work with the marginal likelihood. By not having to sample
all the random effects, the MCMC algorithm performs with increased stability.
For the remainder of this section, we will introduce the joint model for clustering lon-
gitudinal gene expression data. We will describe in detail the data augmentation ap-
proach that relates the gene clusters to binary outcomes and extend the method to
failure time outcomes. Then we will describe the Bayesian MCMC procedure for esti-
mating parameters and ﬁnding clusters for both types of outcomes.
3.2.1 Model for Clustering Longitudinal Gene Expression Data
In the longitudinal microarray setting, we assume that groups of genes behave sim-
ilarly in their expression patterns over time. For every subject i, i = 1;:::;N, we
observe Yi, a matrix of gene expression values measured at various time points t. The
temporal response of the genes is approximated by a random effects model where we
assume a linear change in the gene expressions over time. We allow the dependence
among genes in the same cluster to be induced by subject-cluster speciﬁc random in-
tercepts, cik. Correlation between genes at different times is induced by subject-cluster
speciﬁc random slopes for the time effect, dik. Therefore, for gene j belonging in cluster
k, the model for gene expression is
Yijt = cik(j) + dik(j)t + ijt: (3.1)
Supposing that all the data has been centered at zero, we specify that cik  N(0;2),
dik  N(0;2), and ijt  N(0;2). Also, we assume independence between cik and cik0
and between dik and dik0 for k 6= k0. This implies that genes in different clusters have
covariance equal to zero. We use indicator variables, jk, to denote the membership of
gene j in cluster k and assume the vector of indicators associated with each gene has
a multinomial distribution with probabilities !k. While these are latent, we will later
show how they are used to ﬁnd the clusters.
45For purposes of inference, we will use sufﬁcient statistics for cik and dik instead of all
the expression data. Let h index the times when arrays are collected. Assuming that
patient i has arrays for Ti time points, the sufﬁcient statistics are
Ti P
h=1
Yijth and
Ti P
h=1
thYijth.
For the remainder of the chapter, let Yi denote the expression data in terms of sufﬁcient
statistics.
3.2.2 Model for Clustering Genes using a Binary Outcome
For every patient i, let Xi be a Bernoulli(p) distributed random variable that indicates
whether or not the patient experienced the event. We assume that p, the probability of
experiencing the event, depends on a normally distributed latent variable Zi. Known
as the data augmentation approach (Tanner and Wong, 1987; Albert and Chib, 1993),
Zi can be thought of as an unmeasured underlying process that is directly related to
the value of the observed binary response. Introducing Zi into the model facilitates
the Bayesian model ﬁtting procedure because once we estimate Zi, we no longer need
Xi and the likelihood becomes a simple multivariate normal distribution. Obtaining
these latent parameters is readily achieved by adding an extra step into the MCMC
sampling scheme, the details of which are presented in Section 3.2.4. Augmenting the
data to include Zi requires the speciﬁcation of a function that links the relationship
between Xi and Zi. We use the probit link to describe the relationship, where  is the
cumulative density function of the standard normal distribution:
P(Xi = 1) = (Zi) (3.2)
The dependence of Xi on Zi is straightforward; a smaller value of Zi implies that Xi is
more likely to be zero and a larger value of Zi implies that Xi is more likely to be one.
So far, separate models have been proposed for the clusters of gene expression data
and for the binary outcome. Now we describe the relationship between the two com-
ponents. The gene clusters are related to the binary outcome by a linear relationship
between the cluster random effects and Zi, the continuous latent representation of the
46binary response:
Zi =  +
K X
k=1
k(cik(j) + dik(j)): (3.3)
This is the standard linear regression formulation where  acts as coefﬁcients that de-
scribe the effect of the cluster centers and the cluster slopes on the continuous latent
outcome. For every cluster, the intercept and slope are combined into an average value
for every cluster and are associated with one . We note that it would have been possi-
ble to have different values of k for cik and dik to allow for different effects of intercept
and slope on outcome. Also, we noticed that when  was unconstrained, it tended to
increase without bound. The reason this model may not converge is because the probit
model is much coarser than the normal model and causes the unconstrained coefﬁ-
cients to be non-identiﬁable. We found that convergence occurs when  is constrained
to lie on the unit sphere. A convenient distribution for points on a sphere is the von
Mises-Fisher distribution. We will describe how to generate random variables from
this distribution in Section 3.2.4.
Once we have obtained values for Zi, it is not necessary to account for Xi anymore
because Xi gives no additional information about Zi. This is a very useful property
because the joint distribution of Yi and Zi is multivariate normal and is much easier
to work with as compared to the joint distribution of Yi and Xi. We detail the joint
distributionofYi andZi herebecauseallofthedistributionsthatareusedintheMCMC
sampling algorithm are based on this density. Recall that the random effects have been
integrated out and that Yi = (
Ti P
h=1
Yijth;
Ti P
h=1
thYijth) are the sufﬁcient statistics.
The distribution of f(Yi;Zij;;;;!;;) is multivariate normal with mean
(0;:::;0;)0 and covariance matrix , where
 =

Y Y Y Z
ZY ZZ

:
47Deﬁne the following elements for :
Y Y =

A B
B C

0
Y Z = ZY =

D E

ZZ = (2 + 2)
K P
k=1
2
k
Suppose we let u = (1;:::;J) and v = (1;:::;J) index the gene elements in each
submatrix and let Sk denote the kth cluster set. Let Ti denote the number of arrays that
are available for patient i. Then,
Au;v = 2TiI(u = v) + (2T 2
i + 2(
Ti P
h=1
tih)2)
K P
k=1
I(u;v 2 Sk)
Bu;v = 2(
Ti P
h=1
tih)I(u = v) + (2Ti(
Ti P
h=1
tih) + 2(
Ti P
h=1
tih)(
Ti P
h=1
t2
ih))
K P
k=1
I(u;v 2 Sk)
Cu;v = 2(
Ti P
h=1
t2
ih)I(u = v) + (2(
Ti P
h=1
tih)2 + 2(
Ti P
h=1
t2
ih)2)
K P
k=1
I(u;v 2 Sk)
D1;u = (2Ti + 2
Ti P
h=1
tih)
K P
k=1
I(u 2 Sk)k
E1;u = (2
Ti P
h=1
tih + 2
Ti P
h=1
t2
ih)
K P
k=1
I(u 2 Sk)k
3.2.3 Prior Distributions for Model Parameters
Non-informative prior distributions are speciﬁed for every parameter. The priors for
the hierarchical standard deviation components , , and  are uniform densities on a
wide range. This is approximately equivalent to specifying an Inverse-2 prior distri-
bution for 2, 2, and 2. The vector of cluster probabilities, !, has a conjugate sym-
metric Dirichlet(;:::;) prior, where smaller values of  reﬂect a prior belief that
there should be fewer clusters and larger values suggest the opposite. The cluster
membership variable has a conjugate multinomial prior that depends on the weights,
P(jk = 1) = !k. The intercept term  is given a non-informative uniform prior, and a
von Mises-Fisher prior distribution that is uniform on the K-dimensional unit sphere
is speciﬁed for the vector .
483.2.4 MCMC Algorithm for Clustering Genes using a Binary Out-
come
MCMC methods are iterative procedures that allow one to sample from a variety of
probability distributions. We wish to know the posterior distribution of Z and all the
model parameters. In order to accomplish this, the MCMC algorithm iterates between
draws from the full conditional posterior distributions of Z, , , , , !, , and . As
a result, the collection of samples that are obtained is representative of the posterior
density. The steps are detailed below.
1. Sample the latent variable, Zi.
Write
f(ZijYi;Xi;;;;;!;;)
/ f(XijZi;Yi;;;;;!;;)f(ZijYi;;;;;!;;)
= [(Zi)I(Xi = 1) + ( Zi)I(Xi = 0)]f(ZijYi;;;;;!;;): (3.4)
Since both Zi and Yi are normally distributed, f(ZijYi;;;;!;;) is also nor-
mally distributed with mean
 + Y Z
 1
ZZ(Yi)
and covariance
ZZ   ZY
 1
Y Y Y Z
where Y Y ;Y Z;ZY, and ZZ were previously deﬁned.
Due to the difﬁculty of drawing Zi directly, we implement an acceptance-
rejection algorithm for sampling Zi. Candidate values of Zi are ﬁrst drawn
from f(ZijYi;;;;;!;;). The candidate values are accepted with probabil-
ity (Zi) if Xi = 1 and with probability ( Zi) if Xi = 0. We demonstrated in
Chapter 2 that this generates values of Zi with the correct distribution conditional
on the outcome Xi and the model parameters.
492. Sample the variance parameters: 2, 2, 2.
To simulate the variance parameters, the Metropolis-Hastings algorithm is used.
We draw candidate values from an inverse gamma proposal distribution with
shape parameter s and scale parameter s=. This is approximately equivalent
to specifying an Inverse-2 prior distribution. These tuning parameters are de-
termined experimentally during initial runs to accept proposed samples at the
recommended rate of 40%   45% (Gelman et al., 2004). The proposed values are
accepted with probability proportional to the ratio of the posterior density eval-
uated at the current value to the posterior density evaluated at the candidate
value.
3. Sample the cluster weights, !.
The probability weights associated with belonging in each cluster are sampled
via a Gibbs sampling step. For Gibbs sampling, we draw directly from the full
conditional posterior distribution of !:
f(!j;;;;;;Y;Z) / f(Y;Zj!;;;;;;)f(!)
The full conditional distribution of ! is Dirichlet( + n1;:::; + nK), where nk
is the number of genes in the kth cluster at the current iteration. We found that
 = 1 provides a reasonable result.
4. Sample the cluster memberships, .
The cluster membership parameter is also obtained by Gibbs sampling. The clus-
tering space is explored in a stochastic search where each gene is moved into
every cluster and the likelihood of belonging in each of the K clusters is calcu-
lated. The likelihood of each rearrangement weighted by the current value of !
then becomes the updated multinomial sampling probabilities. Thus, the cluster
membership of gene j is sampled from a multinomial distribution with probabil-
ities proportional to the weighted likelihood given the current parameter values.
50The full conditional distribution of  is given by
f(jjY;Z;;;;;;!) /
K Y
k=1
(f(Y;Zj;;;;;!)  !k)
jk
and we sample directly from this multinomial distribution.
5. Sample the regression intercept, .
The intercept term is sampled using Metropolis-Hastings. A candidate value of 
is drawn from a normal proposal distribution with variance one. Again, the can-
didate value is accepted with probability proportional to the ratio of the posterior
density evaluated at the current value against the posterior density evaluated at
the proposed value.
6. Sample the regression coefﬁcients, .
The vector of coefﬁcients  is obtained by Metropolis-Hastings sampling as well.
As mentioned earlier, we constrain  to exist on the K-sphere such that the sum
of squares equals one. The von Mises-Fisher distribution for a unit vector of di-
mension K is suitable for drawing candidate values with the desired constraint.
Following the steps described in Wood (1994) on how to sample from this distri-
bution, theresultisaK-dimensionalunitvectorwithmeandirection(0;:::;0;1)0.
Applying QR decomposition rotates the vector so that the proposed value of 
becomes the mean direction.
3.2.5 Determining the Number of Clusters
We have been using K to denote the numbers of clusters. To be more speciﬁc, K is
actually the number of empty and non-empty clusters. For our algorithm, only the
maximum value of K needs to speciﬁed in advance. However, the number of non-
empty clusters does not need to be speciﬁed nor does it need to be sampled separately
as a parameter in the algorithm because it is allowed to change with every iteration
when cluster membership is sampled. Since !k is positive for all k regardless of cluster
51size, the multinomial probabilities of belonging in each cluster are always non-zero.
Therefore, there is always a chance that a cluster will end up with no genes or that an
empty cluster will become ﬁlled at any given iteration due to the probabilistic nature
of the allocation.
3.2.6 Extension to Clustering Genes using a Failure Time Outcome
Inthissection, weextendourmodeltoaccommodatefailuretimedatabytreatingtime-
to-event as a series of binary observations at a ﬁxed number of discrete time points that
indicate whether or not the event of interest has occurred yet. This vector of indicator
variables is denoted by Xi(t). If patient i experiences the event at time t, then Xi(t) = 1;
otherwise if the patient has not yet had the event by time t, then Xi(t) = 0.
As in the case with a binary outcome, we augment the data by assuming that the haz-
ard of recovery at any given time depends on a latent continuous variable, Zi(t). The
difference here is that there is a value of Zi(t) for every time point that the event is
evaluated. The values of t do not necessarily need to correspond to the times that the
longitudinal genes are measured. Zi(t) is modeled as
Zi(t) =  +
K X
k=1
k(cik(j) + dik(j)t) + it: (3.5)
We assume it  N(0;1). Here, we use the actual value of t in the model. Again,
more complex models are possible. We could have speciﬁed separate effects for cik
and dikt with a different k for each. Let l = 1;:::;Li index the times that the event is
evaluated. We assume a proportional hazards model where the hazard of the event at
any particular time depends on Zi(tl) as follows:
P(Xi(tl) = 1jXi(tl 1) = 0) = (Zi(tl)): (3.6)
Thehazardofexperiencingtheeventisdifferentateverytimetl, andasZi(tl)increases,
the hazard of the event increases. To model the amount of time it takes for a subject to
52have an event, we assume a negative binomial distribution where the probability of the
event is the hazard of recovery as shown in (3.6). Assuming that patient i is evaluated
for the event at Li time points, the probability of recovering at the lth time point then
becomes
Li 1 Q
l=1
( Zi(tl))(Zi(tLi)).
The MCMC for ﬁtting the survival model follows almost exactly the same steps as
before, except that here the full conditional posterior distribution of the vector Zi is a
product across all the time points:
f(ZijYi;Xi;;;;;!;;)
=
Li Y
l=1
[(Zi(tl))I(Xi(tl) = 1) + ( Zi(tl))I(Xi(tl) = 0)]f(ZijYi;;;;;!;;): (3.7)
The conditional distribution f(ZijYi;;;;;!;;) is normal with mean
 + Y Z
 1
ZZ(Yi)
and covariance
ZZ   ZY
 1
Y Y Y Z
where we redeﬁne
0
Y Z = ZY =

D E
ZZ = F
Again, let u = (1;:::;J) and v = (1;:::;J) index the gene elements in each submatrix
and let l = (1;:::;Li) index the event time. Then,
D
l;u = (2Ti + 2tl
Ti P
h=1
tih)
K P
k=1
I(u 2 Sk)k
E
l;u = (2
Ti P
h=1
tih + 2tl
Ti P
h=1
t2
ih)
K P
k=1
I(u 2 Sk)k
Fl;l0 = (2 + 2tltl0)
K P
k=1
2
k
Candidate values of Zi are drawn from f(ZijYi;;;;;!;;) and are accepted with
probability
Ll Q
l=1
[(Zi(tl))I(Xi(tl) = 1) + ( Zi(tl))I(Xi(tl) = 0)].
533.3 Application
The Inﬂammation and Host Response to Injury research program, also known as the
Glue Grant, is an interdisciplinary study of the genomic changes that occur after a
patient experiences a traumatic injury. The data consists of longitudinal expression
values measured on thousands of genes as well as various clinical measurements and
recovery endpoints for every patient. Patients are followed for 28 days and microar-
rays are available for up to seven time points that are taken at scheduled study visits
following injury. The number of arrays that are available at each time point is pre-
sented in Table 3.1. For our analysis, we use arrays collected starting on day 4. This is
because our model assumes linearity in the time effect and the expression trajectories
appear highly non-linear for the ﬁrst few days after injury.
Table 3.1: Glue Grant array count on various days following injury.
Day 0 1 4 7 14 21 28
Arrays 167 159 147 135 86 53 30
The gene expression values are measured from blood leukocyte cells and have been
pre-processed using dChip, log-transformed and centered prior to analysis. We use a
subset of 87 genes for our cluster analysis that have been pre-selected by Glue Grant
investigators to be those that had signiﬁcant differential expression with at least a two-
fold difference between patients with a clinical outcome of complicated versus uncom-
plicated recovery. Complicated recovery implies the patient had a time to recovery of
more than 14 days, and uncomplicated patients recovered in less than 14 days. We
deﬁne the event of interest to be complicated versus uncomplicated recovery class for
the binary outcome.
Forthesurvivaloutcome, theresponsemeasurementistimetorecovery. Timetorecov-
ery is calculated as the maximum time of cardiovascular, hematologic, hepatic, renal,
or respiratory recovery. The median time to recovery was 7 days. We observe a vector
54of binary responses for every patient with one response at every time point. The re-
sponses are recorded at ﬁxed discrete time points that are the same for every patient.
For the Glue Grant analysis, we use a recovery indicator that is recorded every four
days from day 0 to day 28. We assume that recovery can only occur once for every pa-
tient and that once recovery has occurred, the patient is no longer at risk. Recovery is
the only absorbing state in the model; once a patient recovers, the patient is considered
to have reached the end of the study. If patients do not recover during the course of
the study or if they die prior to the last observed day, they are censored on day 28 and
have an observed indicator vector that consists of all zeroes. Since very few subjects
died from their injuries, mortality was not considered an appropriately sensitive vari-
able for informing distinct clusters. In addition to the ﬁve patients who died within
the ﬁrst 28 days, seven patients did not recover within the ﬁrst 28 days. Both of these
groups of patients are censored at 28 days, since obviously none of these patients will
recover by the end of the study.
For both the binary and survival analyses, we ran eight chains with over-dispersed
starting values. The maximum number of clusters K was set to be 10. We ran 2000
iterations until convergence and discarded 500 iterations as burn-in. Since we only
makesinglegenetransitionswhensamplingclustermembership, thereisatendencyto
under-explore the partition space. Therefore, several chains at different starting values
were implemented and subsequently averaged for purposes of inference. Estimates of
the parameters are shown in Table 3.2.
A visual representation of the clustering is presented in Figure 3.1. Cluster member-
ship is depicted as a heat map that shows the proportion of iterations that every pair
of genes is assigned to the same cluster. In the event of label switching, summarizing
the output as a heat map aids in visualizing the groups and prevents us from having
to follow the movement of the genes at every iteration. Furthermore, heat map visual-
ization has the advantage of providing information about the uncertainty surrounding
the allocations. The Bayesian approach does not assume there is only one correct parti-
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56Table 3.2: Results of longitudinal Glue Grant trauma data analysis with a binary out-
come (complicated vs. uncomplicated recovery) and survival outcome (time to recov-
ery).
Binary outcome Survival outcome
Mean 95% credible interval Mean 95% credible interval
 2.247 (1.575, 2.878) 1.887 (0.923, 2.667)
 2.127 ( 0.924, 2.813) 1.823 (0.826, 2.655)
 1.839 (0.582, 2.531) 1.437 (0.428, 3.009)
 0.731 ( -3.523, 3.057) -0.240 (-0.764, 0.010)
tion, but ratherthat there is a distributionof partitionswhere someare morelikely than
others. The similarity, or concordance, between two genes is measured by the percent-
age of iterations that they are assigned to the same cluster. Concordance is represented
by a color gradient and ranges from 0% (white) to 100% (red). In all three cases, there
are two large non-overlapping groups. When outcome is included however, genes 42-
87 have several breakdown combinations, implying that several partitions have similar
posterior probabilities. On the other hand, when outcome is not used, genes 42-87 clus-
ter together all the times and do not break down into smaller groups. It is possible that
including outcome can produce more clusters if the relationship to gene expression is
strong.
A plot of the expression trajectories of four representative genes is shown in Figure 3.2.
The gene numbers correspond to the axes labels in the heat map. According to the heat
maps, genes 1 and 20 cluster together about half the time, and genes 45 and 80 cluster
together about half the time. However, the pairs never cluster together. One can see in
the plot that there are differences in their trajectories that correspond to the way they
cluster. Though not entirely linear, genes 1 and 20 have a general downward trend,
and genes 45 and 80 have a general upward trend.
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Figure 3.2: Gene expression trajectories of representative genes from different clusters.
583.4 Discussion
In this chapter, we have provided a Bayesian approach for clustering longitudinal mi-
croarray data that uses patient outcome to inform the partitions. Our method is pri-
marily intended for exploratory purposes and pattern discovery. However, the cluster-
ing model can also be used for prediction where the clusters act as prognostic markers
in predicting the outcome.
An advantage of the Bayesian framework is that all the parameters, including those
for cluster membership, are associated with a probability distribution. This implies
that genes do not necessarily interact with the same group of genes all the time, but
may in fact interact with several different networks, a perspective that seems quite
reasonable. Our model allows for correlation between genes in the same cluster and
between repeated measurements of the same gene. We do not need to specify the
exact number of clusters but only need to specify the maximum number of clusters.
Additionally, the longitudinal arrays do not need to be measured at the same time as
the evaluation of recovery status.
Our model can be extended to more complex settings with the inclusion of additional
parameters. Though this would lead to fewer assumptions, the additional parameters
would need to be sampled in extra MCMC steps. For example, there can be separate
coefﬁcients for the intercept and slope effects in the model for outcome. Furthermore,
a non-linear relationship with time can be speciﬁed for the gene trajectory. Splines
can also be used to model the time-course expression to provide the most amount of
ﬂexibility.
The information encoded in microarray data has the potential to contain new insights
aboutthehumangenomethatcouldeventuallyleadtonewdevelopmentsinmedicine.
Uncovering the underlying cluster structure of gene expression data and determining
the functional properties of the gene clusters will help us understand the biological
59basis of events following traumatic injury. Developing a reliable method of predicting
patient recovery can save valuable resources that are required for careful monitoring
of every patient. If we can successfully accomplish these objectives, we can develop
intervention strategies that have the potential of putting more patients on the road to
recovery.
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